Loading…

Browse All Grants

44,293 grants found

Filters
Reset

Showing 41,66141,680 of 44,293 grants

Completed CLINICAL RESEARCH TRAINING FELLOWSHIP GBP
The impact of venous outflow obstruction on venous return to the heart - preload, cardiac function and exercise tolerance (Dr Rachael Morris)
British Heart Foundation King's College London United Kingdom 2021 – 2024

Post-Thrombotic Syndrome (PTS) affects up to 50% of patients who develop thrombosis in the proximal (inferior vena cava, IVC or iliofemoral, IFV) veins.Chronic fibrotic changes, oc...

£2.48M
GBP
Completed CLINICAL RESEARCH TRAINING FELLOWSHIP GBP
Myocardial adaptation and reverse remodelling in aortic regurgitation: Integrating invasive and non-invasive phenotyping by CMR and biopsy (Dr George Thornton)
British Heart Foundation University College London United Kingdom 2021 – 2024

Current guidelines for the management of severe chronic aortic regurgitation (AR) advocate surgical aortic valve replacement (SAVR) when the heart dilates, becomes impaired or when...

£28.45M
GBP
Completed PROJECT GRANT GBP
Targeting mitochondrial metabolic and redox status to treat ischaemia/reperfusion injury
British Heart Foundation University of Cambridge United Kingdom 2021 – 2024

Ischaemia/reperfusion (I/R) injury underlies many pathologies, including myocardial infarction (MI) and stroke, which account for more than a third of overall mortality in the UK.F...

£3.49M
GBP
Completed SENIOR BASIC SCIENCE RESEARCH FELLOWSHIP GBP
Molecular basis of endoglin function in cardiovascular diseases
British Heart Foundation University of Cambridge United Kingdom 2021 – 2026

The aim of my fellowship is to investigate molecular mechanisms of endoglin (ENG) function using structural and biochemical approaches and to validate the findings in human and mur...

£9.5M
GBP
Completed SPRINGBOARD GBP
Mitochondrial function in doxorubicin-induced cardiotoxicity
The Academy of Medical Sciences University of Oxford United Kingdom 2021 – 2024

Doxorubicin (DOX) is a chemotherapeutic drug that can cause serious cardiotoxic side effects leading to heart failure.Different mechanisms have been proposed for this toxicity, tho...

£9.55M
GBP
Completed SPRINGBOARD GBP
Characterising a new family of glycoside hydrolases that target mycobacterial cell wall glycans
The Academy of Medical Sciences Newcastle University United Kingdom 2021 – 2023

The cell walls of pathogenic mycobacteria including the causative agent of Tuberculosis, M. tuberculosis, contribute to their pathogenicity and resistance to many common antibiotic...

£996.7K
GBP
Completed SPRINGBOARD GBP
Molecular coordination between cytoskeletal networks in collective cell migration and its impact on development and disease
The Academy of Medical Sciences Teesside University United Kingdom 2021 – 2024

The overall goal of this research is to gain in-depth understanding of the molecular mechanisms underpinning gut disorders to ultimately discover new biomarkers for early detection...

£994.7K
GBP
Active STRATEGIC SUPPORT: SCIENCE GBP
EPSRC Physics of Life
Wellcome Trust Ukri-Epsrc United Kingdom 2021 – 2027

This partnership between Wellcome and UKRI will support the Physics of Life funding call.Which aims support internationally leading research that requires collaborative, interdisci...

£30M
GBP
Completed MED TECH FULL GBP
System for Kinematic Assessment of Painful Knees with Ultrasound Imaging
Versus Arthritis University of Oxford United Kingdom 2021 – 2023

Development of a system and protocol for measuring in vivo patella tracking during knee flexion using ultrasound imaging in clinics.With a tracked ultrasound scan of the knee using...

£1M
GBP
Completed MED TECH FULL GBP
Development and evaluation of a medical device to monitor arthritis patients at home
Versus Arthritis Ulster University United Kingdom 2021 – 2023

The purpose of this proposal is to develop and evaluate a prototype device, which can monitor the condition of someone with arthritis at home.The proposal scope involves gathering...

£9.62M
GBP
Completed MED TECH FULL GBP
Long-term intraarticular delivery of glucocorticoids from novel particles
Versus Arthritis Queen Mary University of London United Kingdom 2021 – 2023

Glucocorticoids (GCs) are potent anti-inflammatory and analgesic treatments in musculoskeletal diseases and when delivered intraarticularly in arthritic joints they are amongst the...

£982.4K
GBP
Completed RESEARCH CAREERS COMMITTEE - TRAINING INTERVENTION GBP
Characterisation of tissue-resident immune crosstalk in human pancreatic neoplasms and pancreatitis via single-cell transcriptomics
Cancer Research UK University of Cambridge United Kingdom 2021 – 2022

Background Pancreatic cancer is projected to become the second leading cause of cancer mortality in the late 2020s. The current 5-year pancreatic adenocarcinoma (PDAC) survival is...

Completed RESEARCH CAREERS COMMITTEE - TRAINING INTERVENTION GBP
T-cell Receptor Profiling in Early Stage Breast Cancer
Cancer Research UK University of Cambridge United Kingdom 2021 – 2023

Background Immunotherapies have transformed cancer treatment and how we understand and interpret the tumour microenvironment.Furthermore, it is becoming increasingly apparent that...

Completed INFRASTRUCTURE OVERSIGHT COMMITTEE - CENTRE GBP
Hamlet.rt: multi-centre expansion
Cancer Research UK University of Cambridge United Kingdom 2021 – 2024

Background Heuristics, Algorithms and Machine Learning: Evaluation & Testing in Radiation Therapy (Hamlet.rt) is a technology-enabled prospective clinical study aiming to build...

Active DISCOVERY RESEARCH COMMITTEE - PROGRAMME FOUNDATION GBP
Exploiting membrane dynamics to target the assembly of the metastatic matrix niche in ovarian cancer
Cancer Research UK The University of Manchester United Kingdom 2021 – 2027

BACKGROUND Ovarian cancer has a 5-year survival of only 40% and the outlook is worse for the most common form, high-grade serous ovarian cancer (HGSOC). The major lethal step in HG...

Active RESEARCH CAREERS COMMITTEE - FELLOWSHIP GBP
Deciphering the Genomics of Aggressive non-Hodgkin Lymphoma
Cancer Research UK University of Cambridge United Kingdom 2021 – 2027

Background To unravel the biological basis of aggressive non-Hodgkin lymphomas (aNHL), we and others have performed large mutational profiling studies. These reveal considerable ge...

Completed PREVENTION AND POPULATION RESEARCH COMMITTEE - TOBACCO ADVISORY GROUP - PROJECT GBP
Young people’s engagement with e-cigarettes and their marketing: a mixed-methods, engaged project to co-produce recommendations for policy
Cancer Research UK University of Glasgow United Kingdom 2021 – 2024

Background: While adults’ use of e-cigarettes appears to be stable, evidence suggests that experimentation among young people has increased.Despite differences in opinion within th...

Completed RESEARCH CAREERS COMMITTEE - TRAINING INTERVENTION GBP
Third Biennial European Network for the Study of Cholangiocarcinoma
Cancer Research UK University of Edinburgh United Kingdom 2021 – 2022

Background: Cholangiocarcinoma is a cancer of the ducts in the liver and its incidence is increasing.Currently there are few curative options and as a result, five-year survival ha...

Completed CLINICAL RESEARCH COMMITTEE - PROJECT GBP
ELECTRA – intraoperativE eLECtron radioTherapy in Rectal cAncer
Cancer Research UK University of Southampton United Kingdom 2021 – 2025

Background Colorectal cancer is the third most common cancer in the UK and represents the second highest cause of cancer mortality and cancer-related health care expenditure.The re...

Completed EARLY DETECTION AND DIAGNOSIS COMMITTEE - PROJECT GBP
TEP-eDx: Validating the use of Tumour Educated Platelets for early cancer diagnosis
Cancer Research UK University of Oxford United Kingdom 2021 – 2025

Earlier detection greatly improves outcomes for patients with cancer, and studying the gene changes in cancer cells greatly helps in identifying risks and 'tailoring' tre...